The Inhibitory Activity of the Taraxacum mongolicum on Monoamine Oxidase

민들레의 Monoamine Oxidase 저해활성

  • 황금희 (건국대학교 바이오식의약연구센터) ;
  • 박태규 (건국대학교 바이오식의약연구센터)
  • Published : 2006.12.30

Abstract

We examined the inhibitory activities against monoamine oxidase (MAO) of Taraxacum mongolicum in vitro and in vivo methods. Methanol extract of T. mongolicum showed significantly inhibitory activities on MAO-A and MAOB that were prepared from rat brain and liver in vitro. MAO-A and MAO-B activities were potently inhibited by chloroform fraction of T. mongolicum in vitro tests. The $IC_{50}$ values of each fraction on MAO-A are as followed; methanol extracts (0.90 mg/ml), $CHCl_3$ fraction (0.10 mg/ml), EtOAc fraction (0.36 mg/ml). and those on MAO-B are methanol extracts $(0.39{\mu}g/ml)$, $CHCl_3$ fraction $(0.18{\mu}g/ml)$, BuOH fraction $(0.22{\mu}g/ml)$. Those MAO-A and MAO-B activities in vivo tests have different tendency each other. MAO-A activity was increased by the oral administration of ethanol extract of T mon golicum, while MAO-B activity was decreased. The concentration of serotonin of brain tissue after oral administration of ethanolic extract of T. mongolicum is slightly increased in rat. This tendency is not different from the activity of deprenyl which is the well known MAO inhibitor used as a positive control. Based on these results, we can suggest that T. mongolicum may have the effects on the inhibitory activities against MAO. Thess activities of T. mongolicum is considerable for development of functional materials for the purpose of treatment and control of depressant, dementia, Parkinson' disease, stress and promoting exercise.

Keywords

References

  1. Hwang, K. H., Kim, I. R. and Han, Y. N. (1999) Effects of cold and hot drugs on the activity of monoamine oxidase. Kor. J. Pharmacogn. 30: 145-150
  2. Hwang, K. H. and Lim, S. H. (2003) Studies on monoamine oxidase inhibitory activities of Korean medicinal plants classified to cold drugs by the theory of KIMI. Food Science and Biotechnology 12: 238-241
  3. Kang, B. S. (2000) Bonchohak, 6th edition, Young Lim Sa. Seoul, Korea
  4. 이창복 (1999) 대한식물도감, 783. 향문사, 서울, 대한민국
  5. 한국식품공업협회 (2001) 식품공전, 25-34 문영사, 서울, 대한민국
  6. Namba, T. (1993) The Encyclopedia of Wakan-Yaku with Color Pictures Vol. 1. 68-71 Hoikusha, Osaka, Japan
  7. Ko, S. G, Koh, S. H., Jun, C. Y, Nam, C. G, Bae, H. S. and Shin, M. K. (2004) Induction of apoptosis by Saussurea lappa and Pharbitis nil on AGS gastric cancer cells. Biol. Pharm. Bull. 27(10): 1604-1610 https://doi.org/10.1248/bpb.27.1604
  8. Liu, X. R, Han, W. Q. and Sun, D. R. (1992) Treatment of intestinal metaplasia and atypical hyperplasia of gastric mucosa with xiao wei yan powder Zhongguo. Zhong Xi Yi Jie He Za Zhi 10: 602-603
  9. Chen, Z. (1990) Clinical study of 96 cases with chronic hepatitis B treated with jiedu yanggan gao by a double-blind method. Zhong Xi Yi Jie He Za Zhi 2: 71-74
  10. Zheng, M. (1990) Experimental study of 472 herbs with antiviral action against the herpes simplex virus. Zhong Xi Yi Jie He Za Zhi 1: 39-41
  11. Youdim, M. B., Finberg, J. P. and Tipton, K. F. (1988) Handbook of Experimental Harmacology 90(1): 119-192
  12. Sambamoorthi, U., Olfson, M., Walkup, J. T. and Crystal, S. (2003) Diffusion of new generation antidepressant treatment among elderly diagnosed with depression. Med. Care. 41(1): 180-94 https://doi.org/10.1097/00005650-200301000-00019
  13. Laux, G, Philipp, M. and Kohnen, R. (1996) Hypertension with moclobemide. Lancet. 347(9011): 1330-1330
  14. Silberstein, S. D. (2001) Migraine: preventive treatment. Curr. Med. Res. Opin. 17 Suppl. 1: s87-93 https://doi.org/10.1185/0300799039117007
  15. Danisi, F. (2002) Parkinson's disease. Therapeutic strategies to improve patient function and quality of life. Geriatrics 57(3): 46-50
  16. Ahlskog, J. E. (2003) Slowing Parkinson's disease progression: recent dopamine agonist trials. Neurology 60(3): 381-389 https://doi.org/10.1212/01.WNL.0000044047.58984.2F
  17. Sterling, J., Herzig, Y., Goren, T., Finkelstein, N., Lerner, D., Goldenberg, W., Miskolczi, I., Molnar, S., Rantal, F., Tamas, T., Toth, G, Zagyva, A., Zekany, A., Lavian, G., Gross, A., Friedman, R., Razin, M., Huang, W., Krais, B., Chorev, M., Youdim, M. B. and Weinstock, M. S. (2002) Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease. J Med Chem. 45(24): 5260-5279 https://doi.org/10.1021/jm020120c
  18. SAS Institute, Inc. (1990) SAS User's Guide. Statistical Analysis Systems institute, Cary, NC, U.S.A
  19. Daniel, M. B and Stuart, J. E. (1990) Protein Methods. Wiley-Liss, N.Y. U.S.A
  20. Hwang, K. H., Ma, J. Y. and Kim, I. R. (1999) The studies on the theory of KIMI by the activity of monoamine oxidase. Korean J. Herbology 14: 1-14